Biomarkers For Gvhd Risk In Allo-Sct

Biomarkers for GvHD risk in allo-SCT

VJHemOnc – Video Journal of Hematology & HemOnc

Mapping the future of Hemopoietic Cell Transplants: MAGIC Biomarkers

Icahn School of Medicine

The microbiota as a biomarker for GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

Biomarkers for Graft-Versus-Host Disease: What Is a Biomarker?

Managed Healthcare Executive

What is the latest update on biomarkers for assessing GvHD?

Biomarkers for Graft-Versus-Host Disease: The 5 Subtypes of Biomarkers

Managed Healthcare Executive

Biomarkers for Graft-Versus-Host Disease: Biomarkers as Companion Diagnostics

Managed Healthcare Executive

Precision BMT Through Biomarkers

Icahn School of Medicine

Low-dose ATG in combination with PTCy in alloHSCT & biomarkers for GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

Biomarkers for Graft-Versus-Host Disease: Biomarkers and Alternatives to Corticosteroid Treatment

Managed Healthcare Executive

GvHD biomarker discovery and validation

VJHemOnc – Video Journal of Hematology & HemOnc

REG3α as a biomarker and therapeutic target for GVHD

Journal of Clinical Investigation

GvHD highlights: use of biomarkers to guide treatment

VJHemOnc – Video Journal of Hematology & HemOnc

Amphiregulin as a monitoring biomarker during treatment of acute GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

ST2 and REG3α as predictive biomarkers for GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

Post-transplant cyclophosphamide versus standard GvHD prophylaxis after alloSCT for AML & MDS

VJHemOnc – Video Journal of Hematology & HemOnc

How do we stratify risk in patients with GvHD?

How does GvHD affect outcomes for pediatric patients undergoing allo-SCT for ALL?

Key biomarkers in the management of acute GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

Biomarker testing may transform treatment of acute GVHD (Part 1)

MDedge: news and insights for busy physicians